Latest News

  • August 23, 2010

  • Horizon and Sanger Institute Collaboration to Advance the Frontiers of Translational Genomics

  • Wellcome Trust’s Sanger Institute and Horizon Discovery to collaborate to translate the abundance of new information on human genetic variation into more effective treatments for cancer.

  • Read Story

  • August 08, 2010

  • Horizon announces that it has been awarded €300,000 grant under EUFP7 program

  • Horizon Discovery today announced that it is to be part of a new four year EUFP7 personalized medicine consortium.

  • Read Story

  • May 25, 2010

  • Horizon announce a series of new deals signed with leading Pharma & Biotech companies

  • Horizon Discovery (Horizon) today announced it has recently signed new commercial agreements with pharmaceutical companies Merck and Company Incorporated (2 deals), SuperGen Incorporated and Wellstat Biologics Incorporated relating to its X-MAN™ technology.

  • Read Story

  • April 12, 2010

  • Horizon Partners with TGen Drug Development to offer an integrated personalized medicine service

  • A strategic alliance announced today between TGen Drug Development (TD2) and Horizon Discovery Limited will significantly advance personalized medicine.

  • Read Story

  • March 16, 2010

  • Horizon Secures license from the Univ. of Minnesota to new X-MAN Cell lines relating to DNA repair

  • Horizon Discovery (Horizon) today announced it has secured worldwide exclusive rights to a panel of new human isogenic cell models of DNA damage repair developed by Professor Eric A. Hendrickson at the University of Minnesota using its proprietary GENESIS™ platform.

  • Read Story